|LAZMA Cream is indicated for the short‐term (up to 8 weeks)
treatment of moderate to severe melasma of the face in the presence of
measures for sun avoidance, including the use of sunscreens.Adverse Events:
In the controlled clinical trials, the most frequently reported events were
redness, peeling, burning, dryness, and itching at the site of application.